4.6 Article

Fast detection of SARS-CoV-2 RNA via the integration of plasmonic thermocycling and fluorescence detection in a portable device

Journal

NATURE BIOMEDICAL ENGINEERING
Volume 4, Issue 12, Pages 1159-1167

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41551-020-00654-0

Keywords

-

Funding

  1. Institute for Basic Science [IBS-R026-D1]
  2. US NIH [R01CA229777, R21DA049577, U01CA233360]
  3. MGH Scholar Fund
  4. US DOD [W81XWH1910199, W81XWH1910194]
  5. U.S. Department of Defense (DOD) [W81XWH1910199, W81XWH1910194] Funding Source: U.S. Department of Defense (DOD)
  6. National Research Foundation of Korea [IBS-R026-D1-2020-A00, 4120200213582] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

The diagnosis of severe acute respiratory syndrome 2 (SARS-CoV-2) infection by quantitative PCR with reverse transcription (RT-qPCR) typically involves bulky instrumentation in centralized laboratories and an assay time of 1-2 h. Here, we show that SARS-CoV-2 RNA can be detected in 17 min via a portable device integrating reverse transcription, fast thermocycling (via plasmonic heating through magneto-plasmonic nanoparticles) and in situ fluorescence detection following magnetic clearance of the nanoparticles. The device correctly classified all nasopharyngeal, oropharyngeal and sputum samples from 75 patients with COVID-19 and 75 healthy controls, with good concordance in fluorescence intensity with standard RT-qPCR (Pearson coefficients > 0.7 for the N1, N2 and RPP30 genes). Fast, portable and automated nucleic acid detection should facilitate testing at the point of care.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available